Japan's Medteria raises $910K to grow its 60,000-user medical network
What's the deal? MedteriaDealroom has a profile for this one. Try Dealroom →, a Fukuoka-based startup, has raised ¥140 million (about $910,000) in an early-stage round. The total combines a ¥100 million third-party allotment with a ¥40 million capital loan from Japan Finance CorporationDealroom has a profile for this one. Try Dealroom →.
What does it do? Medteria runs a medical communication cloud, also called Medteria, used by roughly 60,000 doctors, other healthcare workers, and medical students. The platform supports information sharing, knowledge storage, and communication across university and hospital communities.
Who's backing it? The equity portion drew Sagin Capital & ConsultingDealroom has a profile for this one. Try Dealroom →, the venture arm of Saga BankDealroom has a profile for this one. Try Dealroom →'s group, alongside a roster of angels. They include Daishi Fukudome, founder of Change HoldingsDealroom has a profile for this one. Try Dealroom →; Koichiro Toyoda, a physician and former chief executive of Medley; and Sadayoshi Notomi and Yoichiro Hamasaki, co-founders of FusicDealroom has a profile for this one. Try Dealroom →.
What's the money for? Medteria plans to expand the platform's features and user base while strengthening its corporate business. That side sells recruitment support, ad placement, and research and marketing services to hospitals and healthcare companies. The round brings total funding to ¥240 million.
Why now? Founded in August 2024, Medteria is still young. It argues that reaching healthcare workers and students precisely — for hiring, marketing, and research — is a persistent challenge in the medical sector, one its community can help solve.
The signal: This is a modest early cheque, and Medteria's bet is that a trusted professional network becomes a distribution channel. By turning 60,000 medical users into a bridge for employers and healthcare firms, it aims to move beyond communication into a broader platform play.
Image credit: Medteria